Merck Keytruda Reduces Cervical Cancer Mortality Risk (NYSE:MRK)

Merck & Co. headquarters in Silicon Valley

Various photographs Merck (New York Stock Exchange:MRK) announced Saturday that its anti-PD-1 therapy Keytruda (pembrolizumab) met the primary endpoint in ...

Merck's Keytruda Reduces Bladder Cancer Risk by 31% (NYSE:MRK)

by Technical Terrence Team

01/26/2024

0

News by Erik S. Lesser/Getty Images merck (New York Stock Exchange: MRK) announced detailed results from its Phase 3 AMBASSADOR ...

Maker Of Coronavirus Trial Drug Remdesivir, Gilead Sciences. Inc., Reports Positive Data Coming From Trials

Gilead Trodelvy with Merck’s Keytruda controls lung cancer

by Technical Terrence Team

09/10/2023

0

Justin Sullivan/Getty Images News Gilead (NASDAQ:GILD) announced Sunday that its antibody-drug conjugate Trodelvy and Merck’s (NYSE:MRK) anti-PD-1 immunotherapy Keytruda cut ...